Austco Healthcare Ltd Signs $2.88m MCS Deal for Fourth Reseller Acquisition

Austco Healthcare acquires MCS for $2.88 million at 3.5x EBITDA, marking its fourth reseller brought in-house and adding $1.88 million in net incremental annual revenue from August 2026.
By Josua Ferreira -
  • Austco Healthcare has signed a binding agreement to acquire MCS for approximately $2.88 million at 3.5x normalised EBITDA, with $2.24 million payable upfront from existing cash and $0.64 million via a performance-linked earnout.
  • The deal is expected to add $1.88 million of net incremental revenue and $0.82 million of incremental EBITDA annually, with earnings accretion anticipated from completion in August 2026.
  • MCS is the fourth reseller Austco has acquired since 2023, following Teknocorp, Amentco, and G&S Technologies, with management reporting all prior acquisitions have integrated successfully.
  • The $1.45 million in product and software MCS purchased from Austco each year is eliminated on consolidation, meaning the $1.88 million revenue uplift is genuinely incremental rather than a restatement of existing Group revenue.
  • Austco will update investors on MCS's contribution to the Group when it releases FY26 full-year results in late August 2026.
Summarise with Ai:

Austco secures fourth reseller acquisition with $2.88m MCS deal

Austco Healthcare (ASX: AHC) has entered into a binding Share Purchase Agreement to acquire 100% of Medical Communications Systems Pty Ltd (MCS), its long-standing certified nurse call reseller in South Australia. The transaction, executed through wholly owned subsidiary Austco Communication Systems Pty Ltd, brings the reseller in-house on a cash-free, debt-free basis.

Total consideration sits at approximately $2.88 million, representing 3.5x MCS’s normalised EBITDA. The deal is expected to be earnings accretive immediately following completion, excluding transaction and integration costs, with completion anticipated in August 2026.

The move reinforces Austco’s disciplined merger and acquisition playbook, extending its direct-sales presence in the Australian healthcare market. For investors, it marks the fourth reseller brought in-house under a repeatable strategy that management has now applied across three prior transactions.

Breaking down the transaction structure

The acquisition is structured on a cash-free, debt-free basis, subject to customary conditions precedent. Upfront cash of approximately $2.24 million will be funded from existing cash reserves, with the balance payable through a performance-based earnout.

Metric Detail
Total consideration ~$2.88m (3.5x normalised EBITDA)
Upfront cash ~$2.24m (subject to working capital & net debt adjustments)
Performance earnout ~$0.64m (estimated)
Funding source Existing cash reserves
Completion August 2026

The earnout mechanics are structured as follows:

  • Calculated at 3.5x MCS’s FY27 EBITDA (annualised from completion to 30 June 2027), less the $2.24 million upfront consideration.

  • Payable in cash following finalisation of Austco’s audited FY27 accounts.

  • The actual earnout may be higher or lower depending on MCS’s performance.

Linking part of the consideration to future performance de-risks the acquisition and aligns the seller’s incentives with continued delivery.

Sponsored

What the acquisition adds to Austco’s numbers

MCS generated total revenue of approximately $3.33 million in FY26. Of that figure, roughly $1.45 million was product and software purchased from Austco, which is already recorded as Austco revenue and therefore eliminated on consolidation.

Only the balance is incremental. On a full year basis, the acquisition is expected to add approximately $1.88 million of net incremental revenue and approximately $0.82 million of incremental EBITDA to the Group.

MCS Acquisition Financial Breakdown

Importantly, the elimination does not affect earnings. Austco retains the margin it earns on supply to MCS, while MCS’s EBITDA is generated from its own installation, service and maintenance work. This distinction matters: the uplift represents genuine earnings contribution rather than a reshuffling of revenue already captured elsewhere in the Group.

Sponsored

The reseller roll-up strategy explained

A certified reseller is an independent business authorised to supply, install and service a manufacturer’s products under a formal partnership. In Austco’s case, resellers deploy its nurse call and healthcare communication systems for hospitals and aged-care facilities.

Acquiring its own resellers gives Austco direct customer relationships, captures the service and installation margin previously earned by a third party, and strengthens overall service delivery. MCS represents the fourth acquisition in a stated sequence:

  1. Teknocorp (2023)

  2. Amentco (2024)

  3. G&S Technologies (2025)

  4. MCS (2026)

According to the announcement, all prior acquisitions have integrated successfully and contributed to Austco. For investors, this establishes a repeatable, tested growth engine rather than a one-off transaction, offering a pattern that can be assessed across multiple prior deals.

Sponsored

About MCS and the integration path

Medical Communications Systems is based in Morphett Vale, South Australia, and has served as Austco’s certified nurse call reseller in the state since 2011. The business employs 12 staff and supplies, installs and services nurse call and healthcare communication systems for healthcare and aged-care customers across South Australia.

MCS will operate as part of Austco’s Australian operations, with key personnel expected to remain following completion. Initial integration priorities include:

  • Customer and employee continuity

  • Alignment of financial and reporting systems

  • Continuity of service to MCS’s South Australian customers

Completion remains subject to a new lease for the MCS premises, key employees entering into new employment agreements, and completion of transaction documents.

CEO Commentary

“MCS has been a trusted Austco reseller in South Australia for many years, and bringing the business in-house is a natural next step. This acquisition follows the same disciplined model as our last three acquisitions: strengthening our direct sales capability, deepening our customer relationships and retaining experienced local people. The transaction structure links part of the consideration to MCS’s future performance, consistent with our approach to M&A and our focus on earnings-accretive growth,” said Clayton Astles, Chief Executive Officer of Austco Healthcare.

What comes next for investors

Austco will provide a further update on the acquisition, including its contribution to the Group, when it releases its FY26 full year results in late August 2026.

The transaction fits a clear investment thesis: disciplined, cash-funded, immediately accretive bolt-on acquisitions that build direct-sales scale in Australia while de-risking consideration through performance-linked earnouts.

Alongside the reseller roll-up, Austco is building Tacera platform recurring revenue through long-term international maintenance contracts, most recently a A$4.2 million, ten-year agreement at Jurong Health Complex in Singapore that locks in service income through to 2036.

Founded in 1986 and headquartered in Port Melbourne, Austco Healthcare is a global provider of healthcare communication and clinical workflow solutions. The company supports more than 5,000 healthcare facilities across over 60 countries through its direct operations and global reseller network, with core products including the Tacera IP nurse call platform.

Sponsored

Don’t Miss the Next Healthcare Sector Move

Big News Blast delivers FREE breaking ASX healthcare news directly to your inbox within minutes of release, complete with in-depth analysis already done for you. Join 20,000+ investors who stay ahead of the market the moment announcements drop. Click the “Free Alerts” button at Big News Blast to start receiving alerts today.


Frequently Asked Questions

What is Austco Healthcare's reseller roll-up strategy?

Austco's reseller roll-up strategy involves acquiring its own certified nurse call resellers to bring customer relationships, installation margins, and service revenue in-house. MCS is the fourth such acquisition since 2023, following Teknocorp, Amentco, and G&S Technologies.

How much will the MCS acquisition add to Austco's revenue?

The acquisition is expected to add approximately $1.88 million of net incremental revenue and $0.82 million of incremental EBITDA to Austco on a full-year basis, after eliminating the $1.45 million in product and software MCS already purchased from Austco.

How is Austco funding the MCS acquisition?

Austco is funding the $2.24 million upfront payment entirely from existing cash reserves, with no new equity issuance required. The remaining consideration of approximately $0.64 million is structured as a performance-based earnout payable after FY27 audited accounts are finalised.

When is the Austco and MCS deal expected to complete?

Completion is anticipated in August 2026, subject to conditions including a new lease for MCS premises and key employees entering new employment agreements. Austco will provide a further update when it releases its FY26 full-year results in late August 2026.

What does MCS actually do and why does it matter to Austco?

Medical Communications Systems is a South Australia-based business with 12 staff that supplies, installs, and services nurse call and healthcare communication systems for hospitals and aged-care facilities. It has been Austco's certified reseller in South Australia since 2011, and bringing it in-house gives Austco direct customer relationships and captures the service and installation margin previously earned by a third party.

Josua Ferreira
By Josua Ferreira
Partnership Director
Josua Ferreira holds a Bachelor of Commerce in Marketing and Advertising and brings a background in publication, business development, and ASX market storytelling. He has worked with listed companies across the resource sector and broader market, combining sharp commercial instincts with a genuine commitment to keeping investors informed.
Learn More
Companies Mentioned in Article

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher